All In MedTech

Device Trial Radar · NCT07727057

A Study of Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With the TRUPULSE™ Generator for Treatment of Ventricular Arrhythmias

Workflow Study of the Dual Energy THERMOCOOL SMARTTOUCH™ SF (DE STSF) Catheter With the TRUPULSE™ Generator for Treatment of Ventricular Arrhythmias (VAs)

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Jul 8, 2026

Primary completion

Sep 30, 2027

Study completion Sep 30, 2027

Sponsor

Lead sponsor
Biosense Webster, Inc.Public (JNJ)
Sponsor type
Industry
First posted
Jul 27, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect information about how safe Dual Energy THERMOCOOL SMARTTOUCH™ SF (DE STSF) catheter with TRUPULSE™ Generator is and how effective a specific procedural workflow is when this ablation system is used to treat ventricular arrhythmias. The main aims of this study are to see whether the abnormal heart rhythm can be successfully treated while maintaining a specific procedural workflow with the catheter and generator during the cardiac ablation and to monitor participant safety after the procedure by checking if the participant has any complications.

Conditions

  • Arrhythmias, Cardiac

Interventions

  • Radiofrequency/Pulsed Field Ablation SystemDevice

    Radiofrequency and pulsed field ablation by Dual Energy THERMOCOOL SMARTTOUCH™ SF (DE STSF) catheter with the TRUPULSE™ generator will be used.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PVC Arm: Effectiveness of the Procedural WorkflowTime frame: At 3 Months post index ablation procedure
  2. SMIVT and SMNIVT arms: Effectiveness of the Procedural WorkflowTime frame: At 6 months post index ablation procedure
  3. Occurrence of Primary Adverse Events (PAE)Time frame: Up to 7 days post index ablation procedure

Locations

6 sites in 3 countries. Site status is shown where the registry gives one.

  • Medizinische Universitat Graz

    Graz, Austria · Recruiting

  • Ordensklinikum Linz GmbH Elisabethinen

    Linz, Austria · Recruiting

  • AZORG campus Aalst Moorselbaan

    Aalst, Belgium · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.